AXIS 2: AX200 for the Treatment of Ischemic Stroke
Phase 2
Completed
- Conditions
- Acute Ischemic Stroke
- Interventions
- Biological: Filgrastim
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2011-12-13
- Lead Sponsor
- Sygnis Bioscience GmbH & Co KG
- Target Recruit Count
- 328
- Registration Number
- NCT00927836
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇧🇪Universitair Ziekenhuis Gent, Gent, Belgium
🇨🇿Faculty Hospital 1, Plzeň - LochotÃn, Czech Republic
© Copyright 2025. All Rights Reserved by MedPath